Drug Shortage Report for TEVA-MELOXICAM
| Report ID | 263134 |
| Drug Identification Number | 02258323 |
| Brand name | TEVA-MELOXICAM |
| Common or Proper name | MELOXICAM 15MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MELOXICAM |
| Strength(s) | 15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 & 30PP |
| ATC code | M01AC |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-07-16 |
| Estimated end date | 2025-11-20 |
| Actual end date | 2025-11-19 |
| Shortage status | Resolved |
| Updated date | 2025-11-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v20 | 2025-11-20 | French | Compare |
| v19 | 2025-11-20 | English | Compare |
| v18 | 2025-11-13 | French | Compare |
| v17 | 2025-11-13 | English | Compare |
| v16 | 2025-10-30 | French | Compare |
| v15 | 2025-10-30 | English | Compare |
| v14 | 2025-10-23 | French | Compare |
| v13 | 2025-10-23 | English | Compare |
| v12 | 2025-10-16 | French | Compare |
| v11 | 2025-10-16 | English | Compare |
| v10 | 2025-10-10 | French | Compare |
| v9 | 2025-10-10 | English | Compare |
| v8 | 2025-10-02 | French | Compare |
| v7 | 2025-10-02 | English | Compare |
| v6 | 2025-08-28 | French | Compare |
| v5 | 2025-08-28 | English | Compare |
| v4 | 2025-08-14 | French | Compare |
| v3 | 2025-08-14 | English | Compare |
| v2 | 2025-07-18 | French | Compare |
| v1 | 2025-07-18 | English | Compare |
Showing 1 to 20 of 20